Certified by Founder Lodge
Sofinnova Investments
United States - Menlo Park, CA
INVESTOR
1 Disclosed Funding Rounds $53,000,000
7 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade. We are a clinical-stage biopharmaceutical
Company | Date | Round | Raised |
---|---|---|---|
Antiva Biosciences, Inc. | April, 27 ,2023 | Series E | $53,000,000 |
Quanta Therapeutics | May, 23 ,2023 | Series D | $50,000,000 |
Star Therapeutics | September, 05 ,2023 | Series C | $90,000,000 |
Aiolos Bio | October, 26 ,2023 | Series A | $245,000,000 |
Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
Marea Therapeutics | June, 20 ,2024 | Series A | $190,000,000 |
Axonis Therapeutics | October, 31 ,2024 | Series A | $115,000,000 |